Forte Biosciences (FBRX) Institutional Ownership $20.07 -0.90 (-4.29%) Closing price 04:00 PM EasternExtended Trading$20.05 -0.02 (-0.12%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Forte Biosciences (NASDAQ:FBRX)CurrentInstitutional OwnershipPercentage77.63%Number ofInstitutional Buyers(last 12 months)38TotalInstitutional Inflows(last 12 months)$73.51MNumber ofInstitutional Sellers(last 12 months)7TotalInstitutional Outflows(last 12 months)$20.02M Get FBRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Forte Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data FBRX Institutional Buying and Selling by Quarter Forte Biosciences Major Shareholders & Ownership History ExportReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/19/2026Bank of America Corp DE21,606$560K0.0%+444.0%0.156% 5/19/2026 Stempoint Capital LP58,020$1.50M0.3%N/A0.418% 5/19/2026 Janus Henderson Group PLC1,188,060$30.81M0.0%-16.7%8.553% 5/18/2026 Royal Bank of Canada13,389$346K0.0%+11.7%0.096% 5/1/2026 Candriam S.C.A.84,803$2.20M0.0%N/A0.611% 2/18/2026 Sphera Funds Management LTD.185,869$5.07M1.0%-60.8%1.483% 2/18/2026 Quadrature Capital Ltd17,573$479K0.0%N/A0.140% 2/18/2026 Millennium Management LLC246,685$6.73M0.0%+105.9%1.969% 2/18/2026 Janus Henderson Group PLC1,425,785$39.16M0.0%+1.6%11.379% 2/18/2026 683 Capital Management LLC40,000$1.09M0.0%N/A0.319% Get the Latest News and Ratings for FBRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Forte Biosciences and its competitors with MarketBeat's FREE daily newsletter. 2/17/2026 J. Goldman & Co LP60,800$1.66M0.0%N/A0.485% 2/17/2026 Jain Global LLC202,433$5.52M0.0%N/A1.616% 2/17/2026 Trexquant Investment LP12,916$352K0.0%N/A0.103% 2/17/2026 Fred Alger Management LLC1,460,971$39.84M0.2%-10.7%11.660% 2/17/2026 ExodusPoint Capital Management LP11,084$302K0.0%N/A0.088% 2/17/2026 Royal Bank of Canada11,986$327K0.0%+6.5%0.096% 2/17/2026 Persistent Asset Partners Ltd10,146$277K0.1%N/A0.081% 2/16/2026 OMERS ADMINISTRATION Corp15,600$425K0.0%N/A0.125% 2/16/2026 Landscape Capital Management L.L.C.15,804$431K0.0%N/A0.126% 2/16/2026 Barclays PLC24,111$658K0.0%+2,840.4%0.192% 2/13/2026 Marshall Wace LLP36,297$990K0.0%+89.4%0.290% 2/13/2026 AWM Investment Company Inc.236,821$6.46M0.6%-9.5%1.890% 2/13/2026 Hudson Bay Capital Management LP16,542$451K0.0%N/A0.132% 2/13/2026 State Street Corp50,721$1.38M0.0%+33.1%0.405% 2/12/2026 Jane Street Group LLC8,344$228K0.0%N/A0.067% 2/12/2026 Federated Hermes Inc.1,765,516$48.15M0.1%+8.0%14.094% 2/12/2026 Alps Advisors Inc.10,289$281K0.0%N/A0.082% 2/10/2026 Goldman Sachs Group Inc.68,023$1.86M0.0%N/A0.543% 2/9/2026 Geode Capital Management LLC124,609$3.40M0.0%+15.0%0.995% 2/6/2026Global Retirement Partners LLC1,000$27K0.0%N/A0.008% 11/17/2025 Mink Brook Asset Management LLC81,312$1.22M0.8%+109.1%0.654% 11/17/2025 Millennium Management LLC119,812$1.80M0.0%+66.1%0.964% 11/17/2025 Fred Alger Management LLC1,636,030$24.54M0.1%+1.1%13.162% 11/17/2025 Citadel Advisors LLC15,633$234K0.0%N/A0.126% 11/17/2025Bank of America Corp DE3,158$47K0.0%+5,641.8%0.025% 11/17/2025 Ameriprise Financial Inc.69,892$1.05M0.0%N/A0.562% 11/12/2025 Dimensional Fund Advisors LP10,765$161K0.0%N/A0.087% 11/7/2025Vanguard Group Inc.566,741$8.50M0.0%+16.4%4.559% 11/5/2025 Envestnet Asset Management Inc.23,347$350K0.0%+23.8%0.188% 11/3/2025 AlphaQuest LLC12,291$184K0.0%-27.3%0.099% The 1934 playbook (Ad)In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it coming — but those who did walked away wealthy.Trump holds that same legal authority today. Advisors close to the administration believe he may use it.If he does, the transfer moves fast. The window to position yourself on the right side is already closing.Get the free report now11/3/2025 Federated Hermes Inc.1,635,380$24.53M0.0%+52.5%13.157% 8/15/2025 Perceptive Advisors LLC68,192$882K0.1%N/A1.036% 8/15/2025 Mink Brook Asset Management LLC38,893$503K0.4%N/A0.591% 8/15/2025 Boothbay Fund Management LLC58,637$758K0.0%-34.3%0.891% 8/15/2025 BVF Inc. IL588,344$7.61M0.3%-1.0%8.941% 8/15/2025 Adage Capital Partners GP L.L.C.333,333$4.31M0.0%N/A5.066% 8/14/2025 Cable Car Capital LP500,000$6.47M1.7%+127.7%7.599% 8/14/2025 Orbimed Advisors LLC1,196,955$15.48M0.4%+101.8%18.191% 8/14/2025 Federated Hermes Inc.1,072,233$13.86M0.0%N/A16.295% 8/8/2025 Geode Capital Management LLC64,110$829K0.0%+6.7%0.974% 8/1/2025Tybourne Capital Management HK Ltd.786,647$10.17M29.4%+26.9%11.950% 8/1/2025 Envestnet Asset Management Inc.18,856$244K0.0%N/A0.286% 7/31/2025 AlphaQuest LLC16,897$218K0.0%+300.7%0.257% 5/16/2025Fred Alger Management LLC910,609$7.07M0.0%-19.7%13.833% 5/14/2025AlphaQuest LLC4,217$33K0.0%N/A0.064% 4/22/2025Garde Capital Inc.3,960$31K0.0%N/A0.060% 2/17/2025Woodline Partners LP204,275$4.64M0.0%N/A3.197% 2/17/2025Tybourne Capital Management HK Ltd.619,981$14.08M3.5%+327.6%9.702% 2/17/2025Orbimed Advisors LLC600,000$13.63M0.3%N/A9.390% 2/17/2025Farallon Capital Management LLC35,000$795K0.0%-51.7%0.548% 2/17/2025Fred Alger Management LLC1,133,944$25.75M0.1%+1,271.2%17.746% 2/17/2025BVF Inc. IL594,282$13.50M0.5%+398.2%9.300% 2/17/2025Acuta Capital Partners LLC18,139$412K0.4%N/A0.284% 2/14/2025Boothbay Fund Management LLC89,191$2.03M0.1%N/A1.396% 2/12/2025Geode Capital Management LLC16,877$383K0.0%+18.3%0.264% 2/12/2025JPMorgan Chase & Co.2,103$48K0.0%+70,000.0%0.033% 11/14/2024Fred Alger Management LLC82,698$462K0.0%-95.5%5.664% 11/14/2024Tybourne Capital Management HK Ltd.144,981$810K0.2%-96.0%9.930% 11/5/2024BML Capital Management LLC70,468$394K0.2%-96.0%4.827% 2/20/2024Cable Car Capital LLC2,031,987$1.67M1.9%N/A5.593% 11/14/2023Fred Alger Management LLC1,838,965$1.22M0.0%N/A5.069% 10/23/2023BML Capital Management LLC1,761,702$1.17M1.1%+1.5%4.856% 4/14/2023BML Capital Management LLC1,735,075$1.75M1.5%+18.7%8.258% 2/13/2023BML Capital Management LLC1,461,364$1.46M1.4%N/A7.185% 5/11/2022GSA Capital Partners LLP51,496$75K0.0%N/A0.349% FBRX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of FBRX shares? During the previous two years, 48 institutional investors and hedge funds held shares of Forte Biosciences. The most heavily invested institutionals were Federated Hermes Inc. ($48.15M), Fred Alger Management LLC ($39.84M), Janus Henderson Group PLC ($30.81M), Orbimed Advisors LLC ($15.48M), Tybourne Capital Management HK Ltd. ($10.17M), Vanguard Group Inc. ($8.50M), and BVF Inc. IL ($7.61M).Learn more on Forte Biosciences' institutional investors. What percentage of Forte Biosciences' stock is owned by institutional investors? 77.63% of Forte Biosciences' stock is owned by institutional investors. Learn more on FBRX's institutional investor holdings. Which institutional investors have been buying Forte Biosciences' stock? Of the 44 institutional investors that purchased Forte Biosciences' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Federated Hermes Inc. ($1.77M), Orbimed Advisors LLC ($1.20M), Fred Alger Management LLC ($1.07M), Tybourne Capital Management HK Ltd. ($641.67K), BVF Inc. IL ($475K), Adage Capital Partners GP L.L.C. ($333.33K), and Cable Car Capital LP ($280.40K). How much institutional buying is happening at Forte Biosciences? Institutional investors have bought a total of 4,454,930 shares in the last 24 months. This purchase volume represents approximately $73.51M in transactions. Which of Forte Biosciences' major shareholders have been selling company stock? The following institutional investors have sold Forte Biosciences stock in the last 24 months: Sphera Funds Management LTD. ($288.44K), Janus Henderson Group PLC ($237.73K), Fred Alger Management LLC ($175.06K), Boothbay Fund Management LLC ($30.55K), AWM Investment Company Inc. ($25K), BVF Inc. IL ($5.94K), and AlphaQuest LLC ($4.61K). How much institutional selling is happening at Forte Biosciences? Institutional investors have sold a total of 767,322 shares in the last 24 months. This volume of shares sold represents approximately $20.02M in transactions. Related Companies AVBP Institutional Ownership CRVS Institutional Ownership GHRS Institutional Ownership WVE Institutional Ownership MLTX Institutional Ownership MPLT Institutional Ownership MAZE Institutional Ownership JBIO Institutional Ownership OLMA Institutional Ownership CMPS Institutional Ownership This page (NASDAQ:FBRX) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Forte Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Forte Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
